SCHEMBL6732492

SCHEMBL6732492

Oc1cccc(NCc2cccnc2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.66
MAPT P10636 4/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
PABPC1 P11940 1/20 0.60
ALDH1A1 P00352 5/20 0.56
KDM4E B2RXH2 3/20 0.55
GAA P10253 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
RAB9A P51151 3/20 0.52
NPC1 O15118 3/20 0.52
HPGD P15428 2/20 0.52
HTT P42858 1/20 0.52
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
USP2 O75604 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
HSD17B10 Q99714 1/20 0.50
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4200916 0.88 LTA4H (0.57) LTA4HMAPTMEN1KMT2APABPC1
SCHEMBL22792637 0.84 LTA4H (0.61) LTA4HMAPTMEN1KMT2APABPC1
SCHEMBL5268459 0.84 HIF1A (0.46) LTA4HMAPTMEN1KMT2APABPC1
SCHEMBL4187374 0.82 FYN (0.67) LTA4HMAPTMEN1KMT2APABPC1
SCHEMBL6730573 0.82 LTA4H (0.72) LTA4HMAPTMEN1KMT2APABPC1
SCHEMBL5605047 0.81 LTA4H (0.82) LTA4HMAPTMEN1KMT2APABPC1
SCHEMBL11510145 0.81 HIF1A (0.64) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL11115803 0.81 ALDH1A1 (0.69) LTA4HMAPTMEN1KMT2APABPC1
SCHEMBL13766316 0.81 LTA4H (0.66) LTA4HMAPTMEN1KMT2APABPC1
SCHEMBL6733048 0.81 LTA4H (0.66) LTA4HMAPTMEN1KMT2APABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016102969-A1 INHIBITION OF HAIR GROWTH THE UNIVERSITY OF MANCHESTER (GB) 2016-06-30 WO claimed
WO-2016102969-A1 INHIBITION OF HAIR GROWTH THE UNIVERSITY OF MANCHESTER (GB) 2016-06-30 WO disclosed
US-6800651-B2 Potentiators of glutamate receptors ELI LILLY AND COMPANY 2004-10-05 US disclosed
US-20040006114-A1 Potentiators of glutamate receptors ELI LILLY AND COMPANY 2004-01-08 US disclosed
EP-1255735-A2 PYRIDINE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS ELI LILLY AND COMPANY (US) 2002-11-13 EP disclosed
WO-2001056990-A2 PYRIDINE DERIVATES AS POTENTIATORS OF GLUTAMATE RECEPTORS ELI LILLY AND COMPANY (US) 2001-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006114-A1 Potentiators of glutamate receptors GRM1, GRIN1, GRM2 LTA4H 1721/4885MAPT 3885/4885MEN1 2793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.